Erythromycin increases gastric antral motility in human premature infants

scientific article published on 01 January 1993

Erythromycin increases gastric antral motility in human premature infants is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000243954
P698PubMed publication ID8373908

P2093author name stringM Miyazaki
T Koizumi
T Tomomasa
T Kuroume
P433issue6
P921main subjecterythromycinQ213511
P304page(s)349-352
P577publication date1993-01-01
P1433published inNeonatologyQ2817272
P1476titleErythromycin increases gastric antral motility in human premature infants
P478volume63

Reverse relations

cites work (P2860)
Q42101699Cisapride reduces neonatal postoperative ileus: randomised placebo controlled trial
Q41692833Disorders of the oesophagus and stomach in infants
Q79226979Erythromycin and feeding intolerance in premature infants: a randomized trial
Q35296967Erythromycin as a prokinetic agent in preterm neonates: a systematic review
Q44634277Establishing Enteral Feeding in Preterm Infants with Feeding Intolerance: A Randomized Controlled Study of Low-dose Erythromycin
Q41017384Gastrointestinal motility in neonatal and pediatric practice
Q80278558High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants
Q35287526Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial
Q37885246Macrolide antibiotics in paediatric infectious diseases
Q77636140Motilin in human milk: identification and stability during digestion
Q34516811Motility disorders. Diagnosis and treatment for the pediatric patient
Q26747576Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature
Q35290712Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants